Establishes key collaborations with industry, U.S. government, and health care providers to help advance COVID-19 vaccine and therapeutic solutionsCurrent quarter […]
Selected HighlightsSecond quarter net loss of $8.4 millionQuarterly Operating EBITDA* of $40.5 millionCash on hand and available credit facilities provide […]